Trials

University Hospitals Birmingham NHS Foundation Trust is a regional and national centre for specialist clinical services.

It is home to some of the country’s leading clinical research institutions, and is dedicated to developing and implementing groundbreaking treatments, technologies and techniques.

  • Optimising the management of chronic hepatitis B (CHB) in children and young people: A phase 2 prospective study to evaluate the use of quantitative hepatitis B surface antigen as a marker to risk stratify patients

    View Trial
  • The Incidence of Juvenile-onset Systemic Lupus Erythematosus in children and young people and their Access to Care in the UK and Republic of Ireland

    View Trial
  • Hepatitis C Dried Blood Spot Testing of Black and Minority Ethnic Groups through Community Pharmacies in Birmingham UK: A pilot project

    View Trial
  • Sequencing Based Analysis of SLE

    Sequencing Based Genetic Analysis of Systemic Lupus Erythematosus (SLE)

    View Trial
  • OCCAMS

    Oesophageal Cancer Clinical and Molecular Stratification Study (OCCAMS): A prospective multicentre trial to determine predictive and prognostic biomarkers and therapeutic targets for Oesophageal and Junctional Adenocarcinoma

    View Trial
  • PREDICT

    Predicting Acute-on-Chronic Liver Failure in Cirrhosis-(PREDICT)

    View Trial
  • PROHS

    Prehospital Resuscitation On Helicopter Study

    View Trial
  • PROCEED

    Patient Reported OutComEs in rarE Disease: (PROCEED)

    View Trial
  • The role of no rinse cleansers in reducing the risk of developing skin conditions such as moisture lesions & incontinence dermatitis which may pre-dispose to a higher risk of tissue breakdown.

    View Trial
  • Natural history and pathogenesis of systemic IgG4 disease

    View Trial